Connor, Clark & Lunn Investment Management (CC&L)’s Strata Critical Medical Inc SRTA Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio SRTA Stock Details SRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-45,939	Closed	-$232K	–	1549
2025 Q3	$232K	Sell	45,939 -76,988	-63%	-$340K	﹤0.01%	1401
2025 Q2	$495K	Buy	+122,927	New	+$400K	﹤0.01%	1258
2024 Q2	–	Sell	-55,634	Closed	-$159K	–	1394
2024 Q1	$159K	Sell	55,634 -101,826	-65%	-$314K	﹤0.01%	1423
2023 Q4	$556K	Buy	157,460 +102,315	+186%	+$294K	﹤0.01%	1020
2023 Q3	$143K	Buy	55,145 +33,258	+152%	+$117K	﹤0.01%	1268
2023 Q2	$86.2K	Buy	+21,887	New	+$69.4K	﹤0.01%	1249

Other funds holding SRTA

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Third Point New York $2.08B AUM 27.04% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NRCM

Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

PLC

Pillsbury Lake Capital San Francisco, California $221M AUM

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s SRTA Position: Q4 2025 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Strata Critical Medical Inc (SRTA) in Q4 2025, closing a stake of 45,939 shares — an estimated $232K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in SRTA in Q2 2023 and held it in 6 quarters. The position peaked at $556K in Q4 2023. 125 funds tracked by Wall St. Rank hold SRTA as of Q4 2025.

Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Strata Critical Medical Inc position as of Q4 2025 after selling out during the quarter.
Connor, Clark & Lunn Investment Management (CC&L) sold 45,939 Strata Critical Medical Inc shares in Q4 2025, an estimated $232K.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Strata Critical Medical Inc in Q2 2023 and held it in 6 quarters.
Connor, Clark & Lunn Investment Management (CC&L)'s Strata Critical Medical Inc position peaked at $556K in Q4 2023.
125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q4 2025.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q4 2025, filed 10 Feb 2026.